SCHEMBL19908236

SCHEMBL19908236

Cc1cnc2c(c1)N(C(C)c1cc(F)c(F)cc1F)CCN2

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19908243 0.87 ALK (0.38) ALK
SCHEMBL1601807 0.87
SCHEMBL13676586 0.79 ALK (0.38) ALK
SCHEMBL19908334 0.76 MTOR (0.32)
SCHEMBL1601457 0.74 ALK (0.38) ALK
SCHEMBL12062729 0.70 ALK (0.49) ALK
SCHEMBL7951142 0.70 LRRK2 (0.33) ALK
SCHEMBL1602398 0.67 ALK (0.38) ALK
SCHEMBL17807826 0.65
SCHEMBL19908318 0.64 ALK (0.39) ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2091951-B1 PYRIDO[2,3-B]PYRAZINE AND [1,8]-NAPHTHYRIDINE DERIVATIVES AS ALK AND C-MET INHIBITORS CEPHALON INC (US) 2018-02-28 EP disclosed